Literature DB >> 18541414

The potential of phages to prevent MRSA infections.

Nicholas H Mann1.   

Abstract

This short review attempts to examine whether there is a potential for the use of phages capable of infecting Staphylococcus aureus to eradicate or reduce nasal colonisation, thereby reducing the overall infection burden in patient populations identified as being at risk from MRSA infections. There is clear evidence that nasal decolonisation may be of benefit to certain patient groups and also that phages can effectively combat experimentally induced S. aureus infections in animals. However, this is not in itself enough to validate the use of phages for decolonisation and, given the appearance of strains resistant to currently used topical antibiotics, there is a need for clinical trials of this prophylactic use of phages.

Entities:  

Mesh:

Year:  2008        PMID: 18541414     DOI: 10.1016/j.resmic.2008.04.003

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  21 in total

1.  Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic.

Authors:  Vijay H Aswani; Sanjay K Shukla
Journal:  Clin Med Res       Date:  2010-10-25

2.  Isolation, characterization and therapeutic potential assessment of bacteriophages virulent to Staphylococcus aureus associated with goat mastitis.

Authors:  A K Mishra; N Sharma; A Kumar; N Kumar; M R Gundallahalli Bayyappa; S Kumar; N Kumar
Journal:  Iran J Vet Res       Date:  2014       Impact factor: 1.376

3.  Phage treatment of human infections.

Authors:  Stephen T Abedon; Sarah J Kuhl; Bob G Blasdel; Elizabeth Martin Kutter
Journal:  Bacteriophage       Date:  2011-03

4.  Pros and cons of phage therapy.

Authors:  Catherine Loc-Carrillo; Stephen T Abedon
Journal:  Bacteriophage       Date:  2011-03

5.  Molecular characterization, structural analysis and determination of host range of a novel bacteriophage LSB-1.

Authors:  Yaming Chai; Hongyan Xiong; Xiangyu Ma; Liqing Cheng; Guorong Huang; Zhonglin Rao Lin Zhang
Journal:  Virol J       Date:  2010-09-28       Impact factor: 4.099

Review 6.  Mobile genetic elements of Staphylococcus aureus.

Authors:  Natalia Malachowa; Frank R DeLeo
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

7.  In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.

Authors:  Jongsoo Jeon; Choong-Min Ryu; Jun-Young Lee; Jong-Hwan Park; Dongeun Yong; Kyungwon Lee
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

8.  Complete genome of Staphylococcus aureus phage SA11.

Authors:  Min Soo Kim; Heejoon Myung
Journal:  J Virol       Date:  2012-09       Impact factor: 5.103

Review 9.  Nanobiosystems for Antimicrobial Drug-Resistant Infections.

Authors:  Foteini Gkartziou; Nikolaos Giormezis; Iris Spiliopoulou; Sophia G Antimisiaris
Journal:  Nanomaterials (Basel)       Date:  2021-04-22       Impact factor: 5.076

Review 10.  The Staphylococci phages family: an overview.

Authors:  Marie Deghorain; Laurence Van Melderen
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.